There is a reflexive assumption that biological samples must ship cold. For stabilized germline DNA, that assumption is often wrong — and acting on it adds cost, complexity, and new failure modes without improving the result. The real question is which samples genuinely require cold chain and which ship better at ambient temperature.
Stabilized saliva DNA is the clearest case for ambient-stable transport. The preservation buffer immobilizes nucleases at collection, holding DNA intact at room temperature for weeks. Properly packaged, such a sample travels by ordinary post with no temperature logging and no phase-change packs to fail — fewer moving parts, fewer ways to go wrong.
Cold chain earns its place where the assay demands it: fresh blood, certain RNA work, and specimens with no stabilization chemistry. There, a qualified insulated container and a temperature logger that proves the sample stayed in range are non-negotiable. The proof is part of the deliverable, not an optional extra.
Either way, packaging compliance is the constant. Most diagnostic specimens ship as UN3373 Category B and require compliant triple packaging regardless of temperature. The decision tree, the IATA rules, and the patient-mailer design are laid out in the complete biospecimen shipping and logistics guide so a clinic can choose ambient or cold chain on evidence rather than reflex.